Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 30, 2009Inflammatory Bowel DiseasesOpen Access

Oral and intravenous iron treatment in inflammatory bowel disease: Hematological response and quality of life improvement

View Full Paper
Ask AI
Bookmark
Share

Authors

Javier P. Gisbert
Javier P. GisbertUniversitat de Miguel Hernández d'ElxFBFernando BermejoComplejo Hospitalario Universitario de SantiagoRPRamón PajaresHospital Universitario Infanta Sofía

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gisbert et al. (2009) studied this question.

synapsesocial.com/papers/6a803a7a0190ac08127014cdhttps://doi.org/10.1002/ibd.20925
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Novel Intravenous Iron Formulation for Treatment of Anemia in Inflammatory Bowel Disease: The Ferric Carboxymaltose (FERINJECT ® ) Randomized Controlled Trial2008 · 349 citations
  2. 2Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial2005 · 109 citations
  3. 3Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease2005 · 143 citations
  4. 4Impact of chronic conditions on quality of life in patients with inflammatory bowel disease2005 · 204 citations
  5. 5Cortisone in Ulcerative Colitis1955 · 2,799 citations